Sort
46,585 grants matching “heart failure”
SPIRRIT-HFPEF - CCC
$1,597,707Eric David Peterson · Duke University · U01 · FY2017 · HL
Myocardial Hypertrophy and Heart Failure
$1,597,506Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2004 · HL
Action for Health in Diabetes (Look AHEAD)
$1,597,345David M Nathan · Massachusetts General Hospital · U01 · FY2011 · DK
Blood Pressure -- Determinants & Controllers
$1,596,932Allen W Cowley · Medical College Of Wisconsin · P01 · FY2010 · HL
IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related Dementia
$1,596,374Meredith Hay · University Of Arizona · U01 · FY2021 · AG
Action for Health in Diabetes (Look AHEAD)
$1,595,718David M Nathan · Massachusetts General Hospital · U01 · FY2012 · DK
Genetically-engineered pig organ transplantation into nonhuman primates
$1,594,492David Kc Cooper · University Of Pittsburgh At Pittsburgh · U19 · FY2014 · AI
Center for Achieving and Sustaining Improved Health in Harlem
$1,593,861Nina A Bickell · Icahn School Of Medicine At Mount Sinai · P60 · FY2007 · MD
Genetically-engineered pig organ transplantation in baboons: immunological and functional studies
$1,593,760David Kc Cooper · Massachusetts General Hospital · U19 · FY2022 · AI
SPECIALIZED CENTER OF RESEARCH IN HEART FAILURE
$1,592,895Brigham And Women'S Hospital · P50 · FY2004 · HL
The Efficacy and Safety of a Selective Estrogen Receptor Beta agonist (LY500307)
$1,592,585Alan Breier · Indiana University Indianapolis · UH3 · FY2015 · TR
CORAL: Clinical Coordinating Center
$1,592,393Christopher J Cooper · University Of Toledo Health Sci Campus · U01 · FY2012 · HL
Oxidative Modification Of Proteins
$1,591,019Rodney L. Levine · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Functional GWAS for LVH using iPS-derived Cardiomyocytes: The HyperGEN ciPS Stud
$1,590,831Ulrich Broeckel · Medical College Of Wisconsin · U01 · FY2014 · HL
Hypertrophic Cardiomyopathy: Understanding the Heterogeneity of Disease Expression and Outcomes
$1,590,760Carolyn Y Ho · Brigham And Women'S Hospital · R01 · FY2022 · HL
Telomeres Diseases
$1,590,725Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
MOLECULAR MECHANISMS OF HEART FAILURE
$1,590,412University Of Cincinnati · P01 · FY2003 · HL
Marinobufagenin as a therapeutic target
$1,588,518Edward Lakatta · National Institute On Aging · ZIA · FY2020 · AG
Minnesota Heart Survey - Renewal
$1,587,813Russell V Luepker · University Of Minnesota · R01 · FY2008 · HL
Expression Genetics in Drug Therapy
$1,587,669Wolfgang Sadee · Ohio State University · U01 · FY2014 · GM
Inhibition Of Renal Injury
$1,587,394Robert A Star · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Mechanisms of Cardioprotection in Ischemia and Failure
$1,587,187Northern California Institute Res &Educ · P01 · FY2003 · HL
Expression Genetics in Drug Therapy
$1,586,888Wolfgang Sadee · Ohio State University · U01 · FY2012 · GM
The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep Diseases
$1,585,308David D. McManus · Univ Of Massachusetts Med Sch Worcester · U54 · FY2019 · HL
Multi-functional anti-thrombotic therapy for coronary microvascular obstruction
$1,582,022Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2023 · HL